Radon health effects
Scientists agree that radon causes lung cancer in humans. Being exposed to radon for a long period of time can lead to lung cancer. In the U.S., radon exposure is the second leading cause of lung cancer after cigarette smoking.
Lung Cancer
ZYKADIA® (ceritinib)
ZYKADIA is a kinase inhibitor indicated for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
EXKIVITY™ (mobocertinib) capsules
EXKIVITY is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test
ALECENSA® (alectinib) capsules
ALECENSA is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test
Radiation lung injury
The lung is an exquisitely radiosensitive organ that can be damaged by external beam radiation therapy. The degree of pulmonary injury is determined by the volume of lung irradiated, the dose and rate of exposure, and potentiating factors
KEYTRUDA® (pembrolizumab) injection
Pembrolizumab is a programmed death receptor-1 (PD 1)-blocking antibody. Pembrolizumab is a humanized monoclonal IgG4 kappa antibody with an approximate molecular weight of 149 kDa.
DOCETAXEL injection
Docetaxel is an antineoplastic agent belonging to the taxoid family indicated for breast cancer, Non-small Cell Lung Cancer (NSCLC), Castration-Resistant Prostate Cancer (CRPC), Gastric Adenocarcinoma and Squamous Cell Carcinoma